Rocket Pharmaceuticals Inc (NAS:RCKT)
$ 22.23 0 (0%) Market Cap: 2.02 Bil Enterprise Value: 1.71 Bil PE Ratio: 0 PB Ratio: 4.56 GF Score: 43/100

Rocket Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) Transcript

Sep 10, 2020 / 05:30PM GMT
Release Date Price: $23.68 (-1.21%)
Mohit Bansal
Citigroup Inc. Exchange Research - Research Analyst

Great. Good afternoon. Thank you, everyone, for joining us today. My name is Mohit Bansal. I'm one of the biotech analysts here at Citi, and I have a pleasure to have Gaurav Shah from Rocket. He's the CEO of the company with us. Thank you, Gaurav, for joining us today.

Gaurav Shah
Rocket Pharmaceuticals, Inc. - CEO, President & Director

My pleasure, Mohit.

Mohit Bansal
Citigroup Inc. Exchange Research - Research Analyst

Great.

Gaurav Shah
Rocket Pharmaceuticals, Inc. - CEO, President & Director

Good to see you and thanks for having us today.

Mohit Bansal
Citigroup Inc. Exchange Research - Research Analyst

Thank you. And those who can see us, you can see that Gaurav is sitting right next to fireside. So we are having a fireside chat today, literally. So I hope you enjoy the conversation.

(Operator Instructions)

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot